The Effect of Adalimumab on the Bone Microstructure in Crohn's Disease (CD) Patients

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. Identifier: NCT01012570
Recruitment Status : Terminated (not enough patients enrolled)
First Posted : November 13, 2009
Last Update Posted : December 4, 2014
Information provided by (Responsible Party):
Gerhard Rogler, University of Zurich

No Study Results Posted on for this Study
  Recruitment Status : Terminated
  Actual Primary Completion Date : August 2011
  Study Completion Date : No date given